Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia

the goal of this observational study is to evaluate the clinical characteristic and outcomes of patients with community-acquired pneumonia admitted to Sohag University Hospital.

the researcher will take medical history and clinical examination and investigations of participants .

the participants will visit the clinic after one month to be reevaluated again .

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Community Acquired Pneumonia (CAP) Community-Acquired Infections Community-Acquired Pneumonia Infections Lung Diseases Pneumonia Respiratory Tract Diseases Respiratory Tract Infections

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Community acquired pneumonia is acute infection of the pulmonary parenchyma that occurs in the community in a patient who has not been hospitalized within 14 days prior to onset of symptoms or hospitalized less than 2 days prior to the onset of symptoms the aim of the study typically focuses on examining the various factors that influence the presentation, management, and outcomes of individuals diagnosed with pneumonia that is acquired outside of a hospital or healthcare setting.

Type of the study: observational study

Outcomes of interest include:

I. Mortality (in hospital and 30 days). II. The need for further mechanical ventilation or ICU admission. III. Duration of hospital stay.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The study will include patients ≥18 years old with community acquired pneumonia

Exclusion criteria

Patients already was diagnosed as active malignancy before admission
Patient on chemotherapy
HIV patients
Indication of mechanical ventilation on admission

Treatment and study plan

Primary outcomes

improved

Time frame: within one month

when the patient is improved and discharged
patients developed complications

Time frame: within one month

when patients developed complications like acute kidney injury , septic shock or Disseminated intravascular coagulopathy
Death of patient

Time frame: within one month

Secondary outcomes

intensive care unit admission

Time frame: within one month

Study contacts

Contact information is provided by the study sponsor or research team.

Rania Abdo Saeed Rania Abdo saeed, MBBCh

CONTACT

[email protected]

+2001093776651

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Dec 4, 2024
Registry last updated: Dec 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed